Vaccines. December 9, Dan Stetson
|
|
- Baldwin Parks
- 6 years ago
- Views:
Transcription
1 Vaccines December 9, 2016 Dan Stetson 441 Lecture #27 Slide 1 of 27
2 Final Announcements Exam Review Session: Tuesday, Dec 13, 11:30 AM-1:20 PM, T-639 Lecturer and TA evaluations: please submit them online (extra credit) Last submission time: December 18 Final Exam: Wednesday, December 14, 8:30-10:20 in T-435 (here) 60 questions (ten more than usual, 60 extra minutes) NOT cumulative: exam will cover lectures Thanks for a great quarter! Good luck! Happy Holidays! 441 Lecture #27 Slide 2 of 27
3 Infectious diseases are the second biggest killer worldwide 2004 WHO Statistics, worldwide Cause % of Deaths 1. Cardiovascular diseases Infectious disease Cancer Respiratory diseases Unintentional injuries 6.23 Low-income, developing countries 1. Lower respiratory infections Coronary heart disease Diarrheal diseases HIV/AIDS Stroke Chronic obstructive pulmonary Tuberculosis Neonatal infections Malaria Prematurity / low birth weight Lecture #27 Slide 3 of 27
4 Vaccines: the greatest triumph of Immunology Best Example: Smallpox a scourge from ~5,000 BCE through Oct 26, 1977 High mortality (up to 90%), disfiguring, extremely virulent 18 th century Europe: leading cause of death (400,000 dead per year) Vaccination (Jenner, 1796) effective but not broadly accepted 1967: million cases worldwide, 2 million deaths. WHO announces global eradication plan in 1967 (spearheaded in large part by William H. Foege, MD University of Washington) 10 years, 465 million vaccine doses, 27 countries: last natural case on Oct 26, 1977 *Sept 11, 1978: one death in UK from an escaped lab strain NOW: No cases in 34 years, viral stocks in two places: US CDC; Koltsovo, Russia 441 Lecture #27 Slide 4 of 27
5 Vaccines protect against a variety of devastating diseases Sam Stetson, 11 months 2014: : 2, : 48,277 *Most residual cases are in unvaccinated individuals (measles, mumps), or long after vaccine wore off (pertussis), or both. 441 Lecture #27 Slide 5 of 27
6 Pertussis is on the rise again 441 Lecture #27 Slide 6 of 27
7 Recent Outbreaks of Vaccine-Preventable Diseases, USA Pertussis (whooping cough) Measles Mumps 441 Lecture #27 Slide 7 of 27
8 Map of Median Incomes in the United States, 2008 The areas with outbreaks tend to be MORE affluent!!! 441 Lecture #27 Slide 8 of 27
9 Vaccines and autism: there is NO documented connection Original report: Andrew Wakefield et al: Lancet, 1998;351: Suggested a causal role for the MMR vaccine in autism and intestinal disorders. Retracted, 2010: Lancet. 2010;375:445. Dozens of ACTUAL epidemiological studies found no increased risk of autism after vaccination. The best: Madsen et al, N Engl J Med 2002; 347: Denmark: EVERY child has extensive medical records. ~540,000 children examined between 1991 and 1998 (440K vaccinated, 97K not vaccinated). NO increase in autism among MMR-vaccinated children; in fact, a slight decrease. Extended to thimerosal preservative (ethylmercury): NO increased risk of autism. Excellent Frontline episode on vaccines: Important points: Correlation does NOT equal causality (think about pirates and global warming) Complacency and ignorance are enabled by the very SUCCESS of vaccines! 441 Lecture #27 Slide 9 of 27
10 Vaccines: HUGE room for improvement ALL good vaccines were discovered empirically, after extensive (and costly) trial and error We really don t know why few vaccines work and most do not There are very few rules for effective vaccine design 441 Lecture #27 Slide 10 of 27
11 Safe relative to the disease: Examples: Smallpox: major side-effects, scars Old Pertussis vaccine (DPT): rash, fever, irritability (New pertussis vaccine (TDaP) fewer side effects but not as good) Neutralizing antibodies underlie the long-term protective effects of nearly ALL good vaccines T-dependent antibody responses most important, but cellular immunity also contributes 441 Lecture #27 Slide 11 of 27
12 Types of Vaccines I: the holy grail 1. Live attenuated vaccines: mostly viruses A strain or isolate of a virus that initiates but cannot complete its infectious cycle in a normal (immunocompetent) host These are generally the best vaccines: robust, long-term memory, excellent recall responses, elicit great antibody titers, many antigens targeted Examples: Oral Polio (Sabin), Measles, Mumps, Rubella (MMR), Smallpox, Varicella (chicken pox) Can be derived from a related virus that infects another host: cowpox -> smallpox These are rare and require strongly cross-reactive immunity Current methods for attenuating virus: serial passaging in heterologous cells 441 Lecture #27 Slide 12 of 27
13 Some issues with live attenuated viruses 1. Few viruses are amenable to attenuation Heterologous cell culture systems don t exist for most viruses The future : 2. Viruses are attenuated in healthy people but can cause disease in immunocompromised people 3. Risk of reversion, especially for viruses with ill-defined attenuation Example: oral polio vaccine (Sabin 3): only 10 out of 7429 nucleotides (0.1%) are different *circulating vaccine-derived poliovirus (cvdpv) is An emerging issue in developing countries with low vaccine coverage: New methods for defined genetic changes hold promise for currently intractable viruses 441 Lecture #27 Slide 13 of 27
14 2. Killed Vaccines: viruses, bacteria An infectious strain that is killed with heat or chemicals Examples: Influenza A, rabies, bubonic plague (Y. pestis), Hepatitis A These are usually safer, but not nearly as good as live attenuated vaccines: antigen loss, PAMP loss, no infection, rapid waning of protective immunity How to make seasonal flu virus: Types of Vaccines II A. Go to rural China and find out which strains are circulating B. Isolate the most prevalent strains C. Infect Chicken eggs D. Harvest virus, treat with formalin, mix with adjuvant (PAMP), add preservative E. Repeat next year (why?) F. Consider what would happen to flu if people stopped co-housing chickens and pigs 441 Lecture #27 Slide 14 of 27
15 Types of Vaccines III 3. Subunit Vaccines: viruses, bacteria Specific proteins from the microbe, but not the live microbe Examples: Hepatitis B virus, Human Papilloma Virus (Gardisil cervical cancer) Pros: Cons: Very safe (no infection), low toxicity Usually not nearly as good as live attenuated vaccines Restricted antigens (many microbial proteins are unstable in isolation) Limited to proteins since glycosylation patterns may differ in producer cells Must be mixed with adjuvants (PAMPs) not that many approved in humans Vehicle for delivery can create unintended consequences Case in point: HIV STEP Vaccine Trial (halted in 2007) Trivalent, cloned into Adenovirus 5 3,000 high-risk, uninfected males and females 441 Lecture #27 Slide 15 of 27
16 Why was the STEP trial halted? Total new infections Viral setpoint in infected individuals The increase in HIV infection of vaccinated subjects correlated strongly with preexisting antibodies to Adenovirus 5 (~40% of Europeans and ~90% of sub-saharan Africans have neutralizing Ad5-specific Abs) Possibly recruited more activated/memory CD4 T cells to mucosal sites 441 Lecture #27 Slide 16 of 27
17 4. Toxoid Vaccines: bacteria Made from inactivated toxic compounds; these toxins, rather than the live microbe, are responsible for disease Examples: Diptheria, Tetanus Types of Vaccines IV and V Pros: Cons: Usually very efficient, toxins ~easy to isolate, elicit good neutralizing Abs Specialized form of vaccine 5. Conjugate Vaccines: bacteria Chemical coupling of a bacterial polysaccharide to a protein (specialized for non-protein antigens) Examples: Haemophilus influenzae type B Reason: polysaccharides usually induce T-independent antibody responses: No CSR or affinity maturation TI-2 responses are weaker/absent in infants Conjugation to protein converts the response to T-dependent through linked recognition 441 Lecture #27 Slide 17 of 27
18 Pathogen features influence eradication efforts Smallpox as an example: a confluence of an effective, stable, cheap attenuated vaccine and key features of the virus 1. Smallpox had no hosts other than humans Zoonotic pathogens: pathogens that can be transmitted to humans from other vertebrate animals (or vice versa, less common). 60% of the ~1415 human pathogens are zoonotic. Influenza A Toxoplasma Rabies Yersinia pestis (bubonic plague) Borellia burgdorfori (Lyme Disease) **Of these, only flu is transmitted from human to human, we are dead end hosts for the rest 441 Lecture #27 Slide 18 of 27 Stetson 12/9/2016
19 Non-zoonotic diseases Malaria: Malaria is a vector-borne disease, but humans are still the only vertebrate host Humans are required for malaria parasite to complete life cycle Legionella pneumophila: Other host is an invertebrate, but this still poses a challenge for vaccines 441 Lecture #27 Slide 19 of 27
20 Pathogen (and political) features influence vaccine efficacy 2. Smallpox had no persistent phase and no asymptomatic carriers People were either killed or recovered (with disfigurements and/or blindness) Contrast: herpesviruses and HIV long latency, often asymptomatic 3. Smallpox induced long-term immunity in survivors Contrast: Influenza A, Malaria, Tuberculosis, which can reinfect and cause morbidity repeatedly. HIV: very few people (if any) naturally eliminate the virus once infected 4. Smallpox was fearful enough that a unified response was mobilized Even overcame less than ideal side-effects of vaccinia virus Contrast: Respiratory infections: usually young, old, immunocompromised 5. Smallpox was a sufficient threat (real or perceived) to wealthy countries Contrast: Malaria, cholera (diarrhea) are almost entirely confined to the developing world 6. There were no effective treatments for Smallpox Contrast: HIV (HAART); TB (antibiotics) for those who can AFFORD them! 441 Lecture #27 Slide 20 of 27
21 What about the diseases for which there are no vaccines? HIV M. Tb Malaria Respiratory 1. No zoonotic host /X 2. No asymptomatic carriers X X 3. Long-term immunity in survivors X X X X 4. Fearful enough to mobilize money 5. Major threat to wealthy countries 6. No effective treatments X +/- X X +/- X X X +/- /X 441 Lecture #27 Slide 21 of 27
22 Vaccine success depends on: A. Properties of the vaccine itself: Safety Efficacy at inducing long-term protective immunity Cost per dose Stability B. Properties of the pathogen being targeted: Host range Asymptomatic carriers/latency Long-term immunity in survivors, rate of reinfection C. Political, financial, social factors: How devastating is having the disease? Existing treatments (for wealthy people)? How is the disease contracted? (STDs, drug use, etc) Overcoming ignorance and misinformation (MMR and autism) 441 Lecture #27 Slide 22 of 27
23 HIV vaccine: challenges on every front Vaccine: Currently not possible to develop live attenuated versions of HIV Vaccines that elicit neutralizing antibodies don t work because of efficient cell-cell transmission No small animal models for HIV infection and vaccine testing **We are only now learning how the innate immune system detects HIV within infected cells Virus: HIV mutates very frequently: not one virus but countless quasispecies (antigen drift) Long asymptomatic carrier phase these carriers transmit HIV depletes the very cells that are required to provide long-lasting immunity Social/political/intellectual: HAART works very well in people who can afford it (even this is huge economic burden) HIV is transmitted by sex and drug use (and transfusions rare now) There are still people who believe HIV does not cause AIDS 441 Lecture #27 Slide 23 of 27
24 The future: Rules -based design of better vaccines The toolbox: Immunology: knowledge of key innate and adaptive immune pathways Toll and TLRs: (Hoffman, Medzhitov and Janeway) TLR4 and LPS: 1998 (Beutler) TLR9 and DNA: 2000 (Akira) TLR3 and dsrna: 2001 (Medzhitov, Flavell) TLR7 and ssrna: 2004 (Reis e Sousa, Hartmann) RIG-I/MDA5: 2004 (Fujita, Gale) Intracellular DNA sensing: 2006, 2009, 2013 (Medzhitov, Barber, Chen) Regulatory T cells: (Sakaguchi, Rudensky) Th17 cells: (Cua, Stockinger, others) Microbiology: pathogenicity, activation, evasion, manipulation of innate immunity Together: Host-microbe interactions that underlie infectious disease and illuminate new strategies for making better vaccines Most of these specific advances have occurred within the last decade 441 Lecture #27 Slide 24 of 27
25 Using innate immunity to design better vaccines A vaccine should trigger the same module as the pathogen 441 Lecture #27 Slide 25 of 27
26 Why are live-attenuated vastly better than killed/subunit vaccines? Attenuated vaccine: YES YES Killed vaccine: YES NO 441 Lecture #27 Slide 26 of 27
27 At what point(s) might live attenuated viruses be better? Live attenuated vaccines Killed/subunit vaccines CD8 CD4 (Infected cell) 1: Antigen and PAMP source 2: CTL target identification CD8 Effector CTL 441 Lecture #27 Slide 27 of 27
Gene Vaccine Dr. Sina Soleimani
Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New
More informationBiomedical Engineering for Global Health. Lecture 9 Vaccine development: from idea to product
Biomedical Engineering for Global Health Lecture 9 Vaccine development: from idea to product Review of lecture 8 Pathogens: Bacteria and Virus Levels of Immunity: Barriers First line of defense Innate
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More informationVaccines. Vaccines ( continued 1) February 21, 2017 Department of Public Health Sciences
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 11 Vaccines Past, Present, Future Learning Objectives 1. Identify the various types of vaccines 2. Describe the role of vaccine in
More informationImmunization (I) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Immunization (I) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1 Realize the significance
More informationVaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
More informationHow does the body defend itself?
Prevention of Infection 2 Immunisation 3 rd BDS B. Martin Major World Causes Of Death COUNTRIES Developing Developed Total x10-6 Population 5400 (80%) 1200 (20%) 6600 CAUSE OF DEATH % % % Infectious diseases
More informationBBS 2711 Virology. Virus Vaccines
BBS 2711 Virology Virus Vaccines Dr Paul Young, Department of Microbiology & Parasitology. p.young@mailbox.uq.edu.au Virus Vaccines First vaccine developed by Jenner in late 1700's against smallpox virus
More informationVaccination and Immunity
Vaccination and Immunity Eric A. Utt, PhD Director, Worldwide Science Policy Pfizer Inc California Immunization Coalition Summit 2012 Completing the Circle: Ensuring Adult & Adolescent Vaccination for
More informationVaccines: Heroes or Villains?
Vaccines: Heroes or Villains? (Hint: It s the first one) James W. Jarvis, MD, FAAFP Senior Vice President/Senior Physician Executive Northern Light Eastern Maine Medical Center 1 Vaccinations: A brief
More informationCopyright regulations Warning
COMMONWEALTH OF AUSTRALIA Copyright regulations 1969 Warning This material has been reproduced and communicated to you by or on behalf of the University of Melbourne pursuant to part VB of the Copyright
More informationExpanded Programme on Immunization (EPI):
Expanded Programme on Immunization (EPI): Introduction Four to five million annual deaths could be prevented by 2015 through sustained and appropriate immunization efforts, backed by financial support.
More informationTrends in vaccinology
Trends in vaccinology Mathieu Peeters, MD Joint Conference of European Human Pharmacological Societies and Joint Conference of European Human Pharmacological Societies and 20th Anniversary of AGAH March
More informationPART A. True/False. Indicate in the space whether each of the following statements are true or false.
MCB 55 Plagues and Pandemics Midterm I Practice questions Read each question carefully. All the questions can be answered briefly, in the space allotted. PART A. True/False. Indicate in the space whether
More information9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in
More informationEconomics of Vaccine Development A Vaccine Manufacturer s Perspective
Economics of Vaccine Development A Vaccine Manufacturer s Perspective Gerald Voss The Value of Vaccines 2 29 diseases are currently preventable by vaccination Global public health Cervical cancer 1 Diphtheria
More informationInfection, Detection, Prevention...
Infection, Detection, Prevention... A disease is any change that disrupts the normal function of one or more body systems. Non infectious diseases are typically caused by exposure to chemicals or are inherited.
More informationDISEASE PREVENTION & ANTIMICROBIAL USE REDUCTION: IMPACT OF VACCINATION
DISEASE PREVENTION & ANTIMICROBIAL USE REDUCTION: IMPACT OF VACCINATION Anwar Hoosen Department of Medical microbiology University of Pretoria & Tswane Academic Division, NHLS 1 VACCINE ACHIEVEMENTS At
More informationVaccines. Magdalena Sobieszczyk, MD, MPH Division of Infectious Diseases Columbia University. Outline
Vaccines Magdalena Sobieszczyk, MD, MPH Division of Infectious Diseases Columbia University Outline Public health impact of vaccines Historical perspective Active vs. Passive Immunization Immune system
More informationPREVENTION OF INFECTIOUS DISEASES
PREVENTION OF INFECTIOUS DISEASES Loughlin AM & Strathdee SA. Vaccines: past, present and future. In Infectious Disease Epidemiology, 2 nd ed, Jones & Bartlett, 2007; p 374. Loughlin AM & Strathdee SA.
More informationA. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010
Who do you think received the most immunologic components in vaccines? Development of which vaccine slowed after the invention of antibiotics? A. Children born in 1942 B. Children born in 1982 C. Children
More informationImmunization. Immunization procedure called vaccination and the immunizing agent called vaccine (or serum in historical references)
Vaccines BIT 120 Immunization Immunization: a procedure designed to increase concentrations of antibodies and/or effector T-cells which are reactive against infection (or cancer). Immunization procedure
More informationThe World Health Organization (WHO) estimate that vaccination averts 2-3 million deaths per year (in all age groups), and up to 1.
Vaccination The World Health Organization (WHO) estimate that vaccination averts 2-3 million deaths per year (in all age groups), and up to 1.5 million children die each year due to diseases which could
More informationOverview Existing, Emerging, and Re-Emerging Communicable Diseases
Overview Existing, Emerging, and Re-Emerging Communicable Diseases Many communicable diseases have existed with us since the beginning of time. Communicable diseases, which are infections we catch from
More information2/20/2019. The need for adult vaccinations. Update on Adult Immunizations. The Need for Adult Vaccinations. Objectives:
The need for adult vaccinations Update on Adult Immunizations Objectives: Recall the latest recommendations on adult vaccinations Detail the importance of adult vaccinations I m not a kid.. Why are you
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More informationImmunity and how vaccines work
Immunity and how vaccines work Dr Mary O Meara National Immunisation Office Objectives of session An understanding of the following principles Overview of immunity Different types of vaccines and vaccine
More informationBiotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.
More informationCommunicable Disease & Immunization
Communicable Disease & Immunization Ingham County Health Surveillance Book 2016 Communicable Disease & Immunization - 1 Communicable Disease & Immunization T he control of communicable disease and immunization,
More informationThe Continued Need for Immunizations in Top Ten Causes of Death in the U.S., 1900 vs Common Questions about Vaccines
The Continued Need for Immunizations in 2016 Stephanie Schauer, Ph.D. Program Manager, Immunization Program April 13, 2016 Ten Great Public Health Achievements United States, 1900-1999 MMWR 1999 Control
More informationThe Continued Need for Immunizations in 2016
The Continued Need for Immunizations in 2016 Stephanie Schauer, Ph.D. Program Manager, Immunization Program April 13, 2016 Wisconsin Department of Health Services Ten Great Public Health Achievements United
More informationCHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
More informationVaccination-Strategies
Vaccination-Strategies Active immunity produced by vaccine Immunity and immunologic memory similar to natural infection but without risk of disease. General Rule: The more similar a vaccine is to the disease-causing
More informationBODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES
BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES Topic 3 This topic links in with MICROBES (from unit 1) 1. What are the 3 types of microbes? 2. Which microbe do antibiotics destroy? 3. What microbe
More informationSession 27: Vaccines. Patricia Fitzgerald-Bocarsly May 18, 2009
Session 27: Vaccines Patricia Fitzgerald-Bocarsly May 18, 2009 A brief history of vaccination Immunity: comes from the Latin immunis meaning exempt Concept dates to 430 B.C. when Thucydides, the historian
More information3. Lymphocyte proliferation (fig. 15.4): Clones of responder cells and memory cells are derived from B cells and T cells.
Chapter 15 Adaptive, Specific Immunity and Immunization* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. Specific
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationVaccine. Design and Manufacturing. Liting Bi. https://en.wikipedia.org/wiki/vaccine
Vaccine Design and Manufacturing Liting Bi https://en.wikipedia.org/wiki/vaccine 1 Outline Vaccine Intro. 4 Vaccine Types 2 Manufacturing Methods 2 Tests & Applications Take-home messages 2 https://www.youtube.com/watch?v=t_me5ef0ne4
More informationvaccines. Lecture 16 Dr. Gary Mumaugh
Vaccines Lecture 16 Dr. Gary Mumaugh Vaccines A vaccine is a form of antigen (substance which stimulates an immune response) used to create a barrier of immunity against a specific disease. The term derives
More informationPrinciples of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
More informationD-LAB HEALTH SP 725. Jose Gomez-Marquez
SP 725 Jose Gomez-Marquez 1 Vaccine Preventable Diseases Causes of 2.5 million child deaths out of 10.5 million child deaths globally, 2002 Source: WHO Wkly Epidemiol Rec. (2006) 81:189-196. 2 Rationale
More informationPlease read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture. Chapters 9, 17 and 8 for next Friday s lectures
Valerie Daggett Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture Chapters 9, 17 and 8 for next Friday s lectures ppt files for first 2 lectures Past exams Principles of
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationEmerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors
Emerging Viruses Part IIb Follow Up from Part I Vaccines and Inhibitors Cellular Responses to Viral Invasion: Restriction Factors Cells fight viral infection using a series of restriction factors Restriction
More informationCS/PoliSci/Statistics C79 Societal Risks & The Law
CS/PoliSci/Statistics C79 Societal Risks & The Law Nicholas P. Jewell Department of Statistics & School of Public Health (Biostatistics) University of California, Berkeley March 19, 2013 1 Nicholas P.
More informationOUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones VACCINES. Produced in partnership with
OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones VACCINES Produced in partnership with OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones Vaccines are one of the greatest
More informationClass 2: Acquired immunity and vaccination (part 1)
Class 2: Acquired immunity and vaccination (part 1) Ed Ishiguro Department of Biochemistry and Microbiology And The UVic Speakers Bureau ishiguro@uvic.ca A quick summary Main properties of innate and acquired
More informationPublic Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
More informationImmunizations Offered
Immunizations Offered Most vaccines commercially available in the United States are available at the health clinic. A partial list of available vaccines follows. For more information about specific vaccines
More informationCONTACTS & ACKNOWLEDGEMENTS
CONTACTS & ACKNOWLEDGEMENTS Snohomish Health District Communicable Disease Surveillance and Response Analysis and publication: Hollianne Bruce, MPH Program Manager: Amy Blanchard, RN, BSN Communicable
More informationPregnancy and Shots! Shots! Shots! An Update. Kelli D Barbour, MD 4 December 2015
Pregnancy and Shots! Shots! Shots! An Update Kelli D Barbour, MD 4 December 2015 Objectives Review recommended adult vaccinations and pregnancy Review recommended immunizations in pregnancy and the puerperium
More informationEconomic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009
Economic aspects of viral hepatitis in Turkey Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009 Vaccines currently recommended for children in National Immunization
More informationAcute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).
Influenza glossary Adapted from the Centers for Disease Control and Prevention, US https://www.cdc.gov/flu/glossary/index.htm and the World Health Organization http://www.wpro.who.int/emerging_diseases/glossary_rev_sept28.pdf?ua=1
More information3.2 Factors Affecting the Immune System
3.2 Factors Affecting the Immune System Traditional First Peoples Medicines Use of nature For many generation plants, animals and earth substances have been used as healing agents. Examples: Indian Hellebore-skin
More informationImmunity & How Vaccines Work
Immunity & How Vaccines Work Immunisation Study Day 30 th November 2016 Talk given today by Dr. Mary Fitzgerald Learning outcome To be able to describe in outline the immune system and how vaccines work
More informationPractical Applications of Immunology. Chapter 18
Practical Applications of Immunology Chapter 18 I. Vaccines A. Definition A suspension of organisms or fractions of organisms that is used to induce immunity (immunologic memory). The mechanism of memory
More informationHistory and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
More informationVACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine
VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper
More informationSanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More informationImmunization and Vaccines
Immunization and Vaccines A parental choice Dr. Vivien Suttorp BSc, MPH, MD, CCFP, FCFP Lead Medical Officer of Health South Zone, Alberta Health Services November 7, 2013 Overview Facts about vaccines
More informationPublic Health, History and Achievements. Dr Faris Al Lami MBChB PhD FFPH
Public Health, History and Achievements Dr Faris Al Lami MBChB PhD FFPH Objectives Define public health. Describe conditions that existed before the advent of modern public health. Describe important achievements
More informationVaccines. Dr. Gary Mumaugh
Vaccines Dr. Gary Mumaugh Vaccines A vaccine is a form of antigen (substance which stimulates an immune response) used to create a barrier of immunity against a specific disease. The term derives from
More informationM I C R O B I O L O G Y
ninth edition TORTORA FUNKE CASE M I C R O B I O L O G Y a n i n t r o d u c t i o n 18 Practical Applications of Immunology PowerPoint Lecture Slide Presentation prepared by Christine L. Case Vaccine
More informationHOW DO VACCINES WORK?
Official Topic from UpToDate, the clinical decision support resource accessed by 700,000+ clinicians worldwide. Available via the web and mobile devices, subscribe to UpToDate at www.uptodate.com/store.
More informationBy:Reham Alahmadi NOV The production of antibodies and vaccination technology
By:Reham Alahmadi NOV 2018 The production of antibodies and vaccination technology Antibody Production The blood contains two types of white blood cell or leukocyte Phagocytes ingest bacteria by endocytosis
More informationSYLLABUS. The Pathology of Infectious Diseases (PATH-217)
SYLLABUS Name of Course: Length of Course: Course Description: Prerequisites: Course Offered By: The Pathology of Infectious Diseases (PATH-217) 3 units, 44 hrs. (4 hrs. lecture/week) The course is a study
More informationCHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationFoundations of Global Health. Communicable Diseases (Part 1): Control & Smallpox Eradication. Communicable Disease Definitions.
Foundations Global Health Communicable Diseases (Part 1): Control & Smallpox Eradication Learning Objectives Identify components the disease triangle and links in the chain transmission Define prevention,
More informationDeaths/yr Efficacy Use Prev Deaths/yr. Influenza 36,000 70% 60% 18,000. Pneumonia 40,000 60% 40% 20,000 HBV 6,000 90% 30% 4,000
Tetanus, Diptheria, Pertussis,! Measles, Mumps, Rubella, Varicella, HPV, Polio Meningococcus, Pneumococcus,! Influenza, Hepatitis B, Hepatitis A,! H influenza, Rabies, Typhoid,! Yellow Fever, Japanese
More informationCHILDHOOD IMMUNIZATIONS. 10 December 2009 Heather Schembari
CHILDHOOD IMMUNIZATIONS 10 December 2009 Heather Schembari Immunity Passive- Immunoglobulins are transported from mother to baby across the placenta. IgA is acquired through breast milk. Baby inherits
More informationChapter 1. Full file at
Chapter 1 1. Which is the best definition of immunity? Answer: B A. The state of having been exposed to a pathogen repeatedly B. The state of being resistant to reinfection with a pathogen C. When an individual
More informationVaccine-Preventable Diseases in Colorado s Children 2009 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD
State of the Health of Colorado s Children Vaccine-Preventable Diseases in Colorado s Children 29 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD Vaccines have been highly effective
More informationViral vaccines. Lec. 3 أ.د.فائزة عبد هللا مخلص
Lec. 3 أ.د.فائزة عبد هللا مخلص Viral vaccines 0bjectives 1-Define active immunity. 2-Describe the methods used for the preparation of attenuated live & killed virus vaccines. 3- Comparison of Characteristics
More informationPreventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
More informationModule 2: Vaccines and drugs: similarities and differences
Module 2: Vaccines and drugs: similarities and differences Vaccine PV Fellowship WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance Accra, Ghana 7 th 18 th September 2015 Learning
More informationPathogens and the immune system
Pathogens and the immune system Veronica Leautaud, Ph.D. vl2@ rice.edu Keck Hall 224 / 232-lab Lecture 8 BIOE 301-Bioengineering and World Health Review of lecture 7 Science Science is the human activity
More informationInfectious Diseases At A Glance in Durham Region
Infectious Diseases At A Glance in Durham Region Last Updated: November 2017 Highlights The rates of all reported infectious diseases combined are highest among youth and young adults aged 15 to 29 and
More informationVaccination schedules in Denmark
Vaccination schedules in Denmark Tyra Grove Krause MD, PhD, Senior consultant Head of Dept. Of Infectious Disease Epidemiology and Prevention Statens Serum Institut e-mail: tgv@ssi.dk Agenda History of
More informationLichenase: a versatile, stable carrier molecule for vaccine and reagent development
Lichenase: a versatile, stable carrier molecule for vaccine and reagent development R. Mark Jones Center for Molecular Biotechnology, Fraunhofer USA New Cells, New Vaccines VII, From Protein to Product
More informationUpdate on Vaccines. Interrupting transmission of infectious diseases 9/28/2017. Introduction. Factors related to emerging infectious diseases
Introduction Update on Vaccines Patsy Jarreau Department of Clinical Laboratory Sciences LSU Health Sciences Center New Orleans, LA Transmission of infectious disease History of vaccination Vaccine preventable
More informationAOHS Global Health. Unit 1, Lesson 3. Communicable Disease
AOHS Global Health Unit 1, Lesson 3 Communicable Disease Copyright 2012 2016 NAF. All rights reserved. A communicable disease is passed from one infected person to another The range of communicable diseases
More informationThe Science of Vaccines:
The Science of Vaccines: Addressing Common Concerns Paul A. Offit Division of Infectious Diseases Children s Hospital of Philadelphia Perelman School of Medicine The University of Pennsylvania Are vaccines
More informationDisease Prevention and Public Health. SPC2P Biology
Disease Prevention and Public Health SPC2P Biology What is disease and should we be concerned about its prevention? A Brief History The black death (bubonic plague) killed between 30% and 60% of the entire
More informationImmunization Update Richard M. Lampe M.D.
Immunization Update 2012 Richard M. Lampe M.D. Immunization Update List the Vaccines recommended for Health Care Personnel Explain why Health Care Personnel are at risk Recognize the importance of these
More informationBurton's Microbiology for the Health Sciences
Burton's Microbiology for the Health Sciences Chapter 11. Epidemiology and Public Health Chapter 11 Outline Epidemiology Interactions Among Pathogens, Hosts and the Environment Chain of Infection Reservoirs
More informationChapter 17. Infectious Diseases
Chapter 17 Infectious Diseases Lesson 1 What is an infectious disease? Infectious disease Is any disease that is caused by an agent that can be passed from one living thing to another. Disease causing
More informationHealth care workers and infectious diseases
Introduction Health care workers and infectious diseases Objectives 1. What is an infectious disease?? 2. What is an infection and disease?? 3. Causes of re-emerging of the problem of the infectious diseases
More informationCase Studies in Ecology and Evolution. 10 The population biology of infectious disease
10 The population biology of infectious disease In 1918 and 1919 a pandemic strain of influenza swept around the globe. It is estimated that 500 million people became infected with this strain of the flu
More informationThe Immune System and Pathology
The Immune System and Pathology The Immune System in Action When a mosquito bites When you breathe When you have allergies When you get a blood transfusion When you die...also called the Lymphatic System
More informationSP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World
MIT OpenCourseWare http://ocw.mit.edu SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World Spring 2009 For information about citing these materials or our
More informationVaccine Preventable Diseases in San Francisco. Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010
Vaccine Preventable Diseases in San Francisco Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010 Section Responsibilities Communicable Disease Control Unit (CDCU): Communicable
More informationDiphtheria. Vaccine Preventable Childhood Diseases. General information
Diphtheria General information Caused by the bacterium Corynebacterium diphtheria. Transmission is most often person-to-person spread via respiratorydroplets. The word diphtheria comes from Greek and means
More informationAchievements in Public Health, Impact of Vaccines Universal... Children -- United States,
1 of 6 2/10/2005 7:40 PM Weekly April 02, 1999 / 48(12);243-248 Achievements in Public Health, 1900-1999 Impact of Vaccines Universally Recommended for Children -- United States, 1990-1998 At the beginning
More informationOverview. Barriers help animals defend against many dangerous pathogens they encounter.
Immunity Overview Barriers help animals defend against many dangerous pathogens they encounter. The immune system recognizes foreign bodies and responds with the production of immune cells and proteins.
More informationUnit B1, B How our bodies defend themselves against infectious diseases
How our bodies defend themselves against infectious diseases 1. Our bodies defend themselves naturally against infections. We also use other methods to protect ourselves against infections and to relieve
More informationIMMUNE RESPONSE OF PLANTS AND ANIMALS
Immunity is an organisms ability to resist disease IMMUNE RESPONSE OF PLANTS AND ANIMALS Living organisms have evolved many defence mechanisms against disease Plants & animals are under threat of infection
More informationLines of Defense. Immunology, Immune Response, and Immunological Testing. Immunology Terminology
Immunology, Immune Response, and Immunological Testing Lines of Defense If the First and Second lines of defense fail, then the Third line of defense is activated. B and T lymphocytes undergo a selective
More information